Goldman Sachs Trims Price Target on Bristol-Myers Squibb to $55 From $56, Buy Rating Maintained

Bristol-Myers Squibb (BMY) has an average hold rating and a price target range of $37 to $75, according to analysts polled by Capital IQ.Price: 40.25, Change: +0.10, Percent Change: +0.25

MT Newswires08:37 ET

Bristol-Myers Squibb: Hold Rating Maintained Amid Growth Challenges and Uncertain Long-Term Prospects

TipRanks00:15 ET

Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'

Sen. Bernie Sanders (I-Vt.) recently expressed his concerns about the high cost of medical care in the United States, highlighting the financial burden it places on patients.

Benzinga21:36 ET

Bristol-Myers Squibb Unusual Options Activity For July 15

Financial giants have made a conspicuous bearish move on Bristol-Myers Squibb. Our analysis of options history for Bristol-Myers Squibb (NYSE:BMY) revealed 10 unusual trades.Delving into the details,

Benzinga14:31 ET

Bristol-Myers Squibb's Q2 2024 Earnings: What to Expect

BarchartJul 15 10:32 ET

Wells Fargo Maintains Bristol-Myers Squibb(BMY.US) With Hold Rating, Maintains Target Price $52

Wells Fargo analyst Mohit Bansal maintains $Bristol-Myers Squibb(BMY.US)$ with a hold rating, and maintains the target price at $52.According to TipRanks data, the analyst has a success rate of 63.9%

Moomoo NewsJul 15 09:33 ET · Ratings